Nasal calcitonin formulations containing chlorobutanol

Details Nasal calcitonin formulations containing chlorobutanol Nasal calcitonin formulations containing chlorobutanol

2004-03-22

2010-10-12

Tsang, Cecilia (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Calcitonin; related peptides

Reexamination Certificate

active

07812120

ABSTRACT:
Compositions suitable for intranasal administration containing calcitonin, chlorobutanol, a pH of about 3.5, and sodium chloride, and an intranasal spray and a pharmaceutical delivery device thereof.

REFERENCES:
patent: 4670419 (1987-06-01), Uda et al.
patent: 4690952 (1987-09-01), Kagatani et al.
patent: 4788221 (1988-11-01), Kagatani et al.
patent: 4985242 (1991-01-01), Sekine et al.
patent: 4988512 (1991-01-01), Azria
patent: 5026825 (1991-06-01), Grebow et al.
patent: 5059587 (1991-10-01), Yamamoto et al.
patent: 5091365 (1992-02-01), Sandow et al.
patent: 5112804 (1992-05-01), Kowarski
patent: 5124315 (1992-06-01), Ceschel et al.
patent: 5153308 (1992-10-01), Sugiyama et al.
patent: 5179079 (1993-01-01), Hansen et al.
patent: 5183802 (1993-02-01), Aliverti et al.
patent: 5200393 (1993-04-01), Weiner
patent: 5204108 (1993-04-01), Illum
patent: 5211950 (1993-05-01), Kobayashi et al.
patent: 5215739 (1993-06-01), Kamishita et al.
patent: 5281580 (1994-01-01), Yamamoto et al.
patent: 5321008 (1994-06-01), Beaumont et al.
patent: 5428006 (1995-06-01), Bechgaard et al.
patent: 5482706 (1996-01-01), Igari et al.
patent: 5482931 (1996-01-01), Harris et al.
patent: 5503827 (1996-04-01), Woog et al.
patent: 5508260 (1996-04-01), Beaumont et al.
patent: 5514365 (1996-05-01), Mardente et al.
patent: 5527771 (1996-06-01), Beaumont et al.
patent: 5554378 (1996-09-01), Uda et al.
patent: 5565423 (1996-10-01), Sandow et al.
patent: 5574006 (1996-11-01), Yanagawa
patent: 5576016 (1996-11-01), Amselem et al.
patent: 5578324 (1996-11-01), Dohi et al.
patent: 5603943 (1997-02-01), Yanagawa
patent: 5654000 (1997-08-01), Poli et al.
patent: 5681811 (1997-10-01), Ekwuribe
patent: 5693608 (1997-12-01), Bechgaard et al.
patent: 5719122 (1998-02-01), Chiodini et al.
patent: 5725852 (1998-03-01), Igari et al.
patent: 5725871 (1998-03-01), Illum
patent: 5733569 (1998-03-01), Azria et al.
patent: 5759565 (1998-06-01), Azria et al.
patent: 5859048 (1999-01-01), Oohashi et al.
patent: 5948749 (1999-09-01), Igarashi et al.
patent: 6087338 (2000-07-01), Veronesi et al.
patent: 6149893 (2000-11-01), Mardente et al.
patent: 6161731 (2000-12-01), Sigg
patent: 6174857 (2001-01-01), Burk
patent: 6221367 (2001-04-01), Milstein et al.
patent: 6665421 (2003-12-01), Farina
patent: 2002/0010428 (2002-01-01), Vedrine et al.
patent: 2002/0012688 (2002-01-01), Dohi et al.
patent: 2002/0015737 (2002-02-01), Shih
patent: 2002/0031558 (2002-03-01), Yoo
patent: 2002/0037836 (2002-03-01), Henriksen
patent: 2002/0068092 (2002-06-01), Bosch et al.
patent: 2002/0076441 (2002-06-01), Shih
patent: 2002/0107265 (2002-08-01), Chen et al.
patent: 2002/0110525 (2002-08-01), Adjei et al.
patent: 2002/0110527 (2002-08-01), Zhu et al.
patent: 2002/0110528 (2002-08-01), Zhu et al.
patent: 2003/0018416 (2003-01-01), Farina et al.
patent: 0115627 (1982-12-01), None
patent: 0 111 841 (1984-06-01), None
patent: 0 115 627 (1984-08-01), None
patent: 0 183 527 (1986-06-01), None
patent: 0 193 372 (1986-09-01), None
patent: 0 358 234 (1990-03-01), None
patent: 0 371 010 (1990-05-01), None
patent: 0 418 697 (1991-03-01), None
patent: 0 471 618 (1991-08-01), None
patent: 0 489 217 (1992-06-01), None
patent: 2 177 914 (1987-02-01), None
patent: WO 99/16427 (1999-04-01), None
http://www.webster.com/dictionary/composition Definition of Composition.
Physicians Desk Reference, 2002 edition, p. 2375.
Hallen et al., “Benzalkonium Chloride in Nasal Decongestive Sprays has a Long-Lasting Adverse Effect on the Nasal Mucosa of Healthy Volunteers,”Clin. Exp. Allergy, vol. 25, pp. 401-405 (1995).
Berg et al., “The Effect of Decongestive Nosedrops on Human Respiratory Mucosa in Vitro,”Larynogoscope, 104: pp. 1153-1158 (1994).
Braga et al., “The Effects of Calcitonin Nasal Preparations and Their Excipients on Mucociliary Clearance in an Ex-Vivo Frog Palate Test,”J. Pharm. Pharmacol., 44: pp. 938-940 (1992).

Affiliated with

Also associated with

Rating

Nasal calcitonin formulations containing chlorobutanol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nasal calcitonin formulations containing chlorobutanol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nasal calcitonin formulations containing chlorobutanol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4231047